Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - Loss AllowanceNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Prepaid Assets: 2011-2025

Historic Prepaid Assets for RedHill Biopharma (RDHL) over the last 11 years, with Jun 2025 value amounting to $1.0 million.

  • RedHill Biopharma's Prepaid Assets rose 1035.19% to $1.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.0 million, marking a year-over-year increase of 1035.19%. This contributed to the annual value of $1.1 million for FY2024, which is 60.59% down from last year.
  • Per RedHill Biopharma's latest filing, its Prepaid Assets stood at $1.0 million for Q2 2025, which was down 8.51% from $1.1 million recorded in Q4 2024.
  • Over the past 5 years, RedHill Biopharma's Prepaid Assets peaked at $5.2 million during Q1 2023, and registered a low of -$108,000 during Q2 2024.
  • Moreover, its 3-year median value for Prepaid Assets was $1.2 million (2023), whereas its average is $1.9 million.
  • As far as peak fluctuations go, RedHill Biopharma's Prepaid Assets slumped by 108.08% in 2024, and later skyrocketed by 1,035.19% in 2025.
  • Quarterly analysis of 5 years shows RedHill Biopharma's Prepaid Assets stood at $4.7 million in 2021, then fell by 5.88% to $4.4 million in 2022, then plummeted by 36.15% to $2.8 million in 2023, then crashed by 60.59% to $1.1 million in 2024, then surged by 1,035.19% to $1.0 million in 2025.
  • Its Prepaid Assets was $1.0 million in Q2 2025, compared to $1.1 million in Q4 2024 and -$108,000 in Q2 2024.